Keyphrases
Chronic Lymphocytic Leukemia
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
Early Clinical Exposure
100%
Chronic Lymphocytic Leukemia Cells
80%
Leukemia Cells
60%
Chemokine Ligand 12 (CXCL12)
60%
CXCR4 Antagonist
60%
Human Mesenchymal Stem Cells (hMSCs)
40%
Microenvironment
40%
Plerixafor
40%
Leukemia Patients
20%
Leukemia
20%
Tumor Cells
20%
Transmembrane
20%
Rituximab
20%
Clinical Experience
20%
Drug Resistance
20%
Marrow
20%
Cell Migration
20%
Chemokine Receptor
20%
G Protein-coupled
20%
Ongoing Clinical Trials
20%
Stromal Cell-derived factor-1 (SDF-1)
20%
Cell Homing
20%
Chemosensitization
20%
AMD3100
20%
Extramedullary
20%
Anti-CD20 Antibody
20%
Close Contact
20%
Cell Mobilization
20%
Disease Model
20%
Growth Resistance
20%
CXCR4/CXCL12 Axis
20%
T140
20%
Resistance Signal
20%
Mesenchymal Stromal Cells
20%
Tumor-stroma Interaction
20%
Conventional Drugs
20%
Easy Access
20%
Mozobil
20%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Leukemia Cell
87%
Plerixafor
50%
Chemokine Receptor CXCR4 Antagonist
37%
Bone Marrow Stromal Cell
25%
Neoplasm
12%
Leukemia
12%
Clinical Trial
12%
Tumor Cell
12%
Sensitization
12%
Adhesive Agent
12%
Rituximab
12%
Cell Migration
12%
Chemokine Receptor
12%
Guanine Nucleotide Binding Protein
12%
Drug Resistance
12%
Stroma
12%
Mesenchymal Stem Cell
12%
Stromal Cell Derived Factor 1
12%
T 140
12%
Disease Model
12%
CD20 Antibody
12%
Cell Homing
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Leukemia
50%
Plerixafor
50%
Chemokine Receptor CXCR4 Antagonist
37%
Neoplasm
25%
Clinical Trial
12%
Drug Resistance
12%
Rituximab
12%
Chemokine Receptor
12%
Guanine Nucleotide Binding Protein
12%
Adhesive Agent
12%
T 140
12%
Stromal Cell Derived Factor 1
12%
CD20 Antibody
12%
Disease Model
12%
Biochemistry, Genetics and Molecular Biology
CXCR4
100%
Stromal Cell
33%
Cell Migration
11%
Clinical Trial
11%
Drug Resistance
11%
Sensitization
11%
Chemokine Receptor
11%
G Protein
11%
CD20
11%
Stromal Cell-Derived Factor 1
11%
Rituximab
11%
Cell Homing
11%